OR14C36

Across TCGA pan-cancer cohorts, OR14C36 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated OR14C36 data layer compared with 7 for mutation status.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher OR14C36 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR14C36 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

ACC, KIRC, and THYM are the cancer types where OR14C36 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.202	0.811	<.001	108	view →
KIRC	DFS	Tertile	III,IV	0.212	0.762	<.001	90	view →
THYM	OS	Tertile	All	0.291	0.893	<.001	87	view →
LUAD	DFS	Tertile	IV	0.045	0.717	<.001	72	view →
UCEC	OS	Tertile	All	0.729	0.930	<.001	36	view →
MESO	OS	Tertile	IV	0.036	0.602	<.001	36	view →
THCA	DFS	Tertile	All	0.087	0.868	<.001	36	view →
OV	OS	Tertile	IV	0.022	0.760	<.001	36	view →
STAD	OS	Tertile	III,IV	0.251	0.640	.001	27	view →
LAML	DFS	Tertile	All	0.182	0.460	.017	18	view →
LUSC	DFS	Tertile	All	0.304	0.711	.024	12	view →
SKCM	OS	Tertile	All	0.612	0.306	.032	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

OR14C36–ACC (OS)

Open the ACC breakdown →